There’s Finally Some Hope on Excessive Executive Pay

Could any corporate execs walking our world today be any greedier than the execs who run Big Pharma? Hard to say. But out-grasping Big Pharma, suggests a new report out of the U.S. Senate Committee on Health, Education, Labor, and Pensions, would certainly require some serious greed. Consider, for instance, the pay record of the Big Pharma colossus Johnson & Johnson. Two years ago, Johnson & Johnson pocketed $17.9 billion in profits, Read More